Lyell Immunopharma Inc

Lyell Immunopharma insiders sell shares for tax liquidity, not confidence drops, while the stock remains 12% above its 52‑week low after a CAR‑T rally.

Lyell Immunopharma’s insider buying spree signals executive confidence amid high volatility—what this means for investors and the company’s next steps.